North Middlesex Hospital — London

Public research footprint of North Middlesex Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lung Cancer · Prostate Cancer · Breast Cancer · Colorectal Cancer

Recently updated registry entries

NCT04116047 — CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) (Active Not Recruiting)
NCT03155997 — Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in… (Active Not Recruiting)
NCT03358472 — Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at North Middlesex Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.